6. LeCouter J, Zlot C, Tejada M, Peale F, Ferrara N (2004) Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization. Proc Natl Acad Sci U S A 101: 16813–16818. 7. Lin DC, Bullock CM, Ehlert FJ, Chen JL, Tian H, et al. (2002) Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor. J Biol Chem 277: 19276–19280. 8. Soga T, Matsumoto S, Oda T, Saito T, Hiyama H, et al. (2002) Molecular cloning and characterization of prokineticin receptors. Biochim Biophys Acta 1579: 173–179. 9. Battersby S, Critchley HO, Morgan K, Millar RP, Jabbour HN (2004) Expression and regulation of the prokineticins (endocrine gland-derived vascular endothelial growth factor and Bv8) and their receptors in the human endometrium across the menstrual cycle. J Clin Endocrinol Metab 89: 2463–2469. 10. Kisliouk T, Levy N, Hurwitz A, Meidan R (2003) Presence and regulation of endocrine gland vascular endothelial growth factor/prokineticin-1 and its receptors in ovarian cells. J Clin Endocrinol Metab 88: 3700–3707. 11. Guilini C, Urayama K, Turkeri G, Dedeoglu DB, Kurose H, et al. (2010) Divergent roles of prokineticin receptors in the endothelial cells: angiogenesis and fenestration. Am J Physiol Heart Circ Physiol 298: H844–852. 12. Bullock CM, Li JD, Zhou QY (2004) Structural determinants required for the bioactivities of prokineticins and identification of prokineticin receptor antagonists. Mol Pharmacol 65: 582–588. 13. Zhou QY, Meidan R (2008) Biological function of prokineticins. Results Probl Cell Differ 46: 181–199. 14. Lin R, LeCouter J, Kowalski J, Ferrara N (2002) Characterization of endocrine gland-derived vascular endothelial growth factor signaling in adrenal cortex capillary endothelial cells. J Biol Chem 277: 8724–8729. 15. Kisliouk T, Podlovni H, Spanel-Borowski K, Ovadia O, Zhou QY, et al. (2005) Prokineticins (endocrine gland-derived vascular endothelial growth factor and BV8) in the bovine ovary: expression and role as mitogens and survival factors for corpus luteum-derived endothelial cells. Endocrinology 146: 3950–3958. 16. Nebigil CG (2009) Prokineticin receptors in cardiovascular function: foe or friend? Trends Cardiovasc Med 19: 55–60. 17. Balboni G, Lazzari I, Trapella C, Negri L, Lattanzi R, et al. (2008) Triazine compounds as antagonists at Bv8-prokineticin receptors. J Med Chem 51: 7635–7639. 18. Coats SJ, Dyatkin AB, He W, Lisko J, Miskowski TA, et al. (2008) Prokineticin 2 receptor antagonists. US2008/ 0045535A1. 19. Coats SJ, Dyatkin AB, He W, Lisko J, Miskowski TA, et al. (2009) Amino- heteroaryl-containing Prokineticin 1 receptor antagonists. US2009/ 0163505A1. 20. Ralbovsky JL, Lisko JG, Palmer JM, Mabus J, Chevalier KM, et al. (2009) Triazinediones as prokineticin 1 receptor antagonists. Part 1: SAR, synthesis and biological evaluation. Bioorg Med Chem Lett 19: 2661–2663. 21. Sela I, Golan G, Strajbl M, Rivenzon-Segal D, Bar-Haim S, et al. (2010) G protein coupled receptors -in silico drug discovery and design. Curr Top Med Chem 10: 638–656. 22. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, et al. (2000) Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289: 739–745. 23. Rosenbaum DM, Rasmussen SGF, Kobilka BK (2009) The structure and function of G-protein-coupled receptors. Nature 459: 356–363. 24. Sprang SR (2011) Cell signalling: Binding the receptor at both ends. Nature 469: 172–173. 25. Levit A, Barak D, Behrens M, Meyerhof W, Niv MY (2011) Homology model- assisted elucidation of binding sites in GPCRs. Methods in Molecular Biology In press. 26. Yarnitzky T, Levit A, Niv MY (2010) Homology modeling of G-protein-coupled receptors with X-ray structures on the rise. Curr Opin Drug Discov Devel 13: 317–325. 27. Rognan D (2010) Structure-Based Approaches to Target Fishing and Ligand Profiling. Molecular Informatics 29: 176–187. 28. Yang SY (2010) Pharmacophore modeling and applications in drug discovery: challenges and recent advances. Drug Discov Today 15: 444–450. 29. Roy A, Kucukural A, Zhang Y (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 5: 725–738. 30. Notredame C, Higgins DG, Heringa J (2000) T-Coffee: A novel method for fast and accurate multiple sequence alignment. J Mol Biol 302: 205–217. 31. Brooks BR, Brooks CL 3rd, Mackerell AD Jr., Nilsson L, Petrella RJ, et al. (2009) CHARMM: the biomolecular simulation program. J Comput Chem 30: 1545–1614. 32. Krivov GG, Shapovalov MV, Dunbrack RL, Jr. (2009) Improved prediction of protein side-chain conformations with SCWRL4. Proteins 77: 778–795. 33. Ballesteros JA, Weinstein H (1995) Integrated methods for the construction of three dimensional models and computational probing of structure function relations in G protein-coupled receptors. Methods Neurosci 25: 366–428. 34. Venkatachalam CM, Jiang X, Oldfield T, Waldman M (2003) LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. J Mol Graph Model 21: 289–307. 35. Laurie AT, Jackson RM (2005) Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites. Bioinformatics 21: 1908–1916. Small-Molecule Binders of Prokineticin Receptors 36. Hernandez M, Ghersi D, Sanchez R (2009) SITEHOUND-web: a server for ligand binding site identification in protein structures. Nucleic Acids Res 37: W413–416. 37. Barnum D, Greene J, Smellie A, Sprague P (1996) Identification of common functional configurations among molecules. Journal of Chemical Information and Computer Sciences 36: 563–571. 38. Thompson WJ, Melamed, Y J (2007) Morpholine carbozamide prokineticin receptor antagonists. Patent WO2007/ 067511. 39. Irwin JJ, Shoichet BK (2005) ZINC–a free database of commercially available compounds for virtual screening. J Chem Inf Model 45: 177–182. 40. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, et al. (2008) DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 36: D901–906. 41. Krammer A, Kirchhoff PD, Jiang X, Venkatachalam CM, Waldman M (2005) LigScore: a novel scoring function for predicting binding affinities. J Mol Graph Model 23: 395–407. 42. Hanson MA, Stevens RC (2009) Discovery of new GPCR biology: one receptor structure at a time. Structure 17: 8–14. 43. Ivanov AA, Barak D, Jacobson KA (2009) Evaluation of homology modeling of G-protein-coupled receptors in light of the A(2A) adenosine receptor crystallographic structure. J Med Chem 52: 3284–3292. 44. Mobarec JC, Sanchez R, Filizola M (2009) Modern Homology Modeling of G- Protein Coupled Receptors: Which Structural Template to Use? J Med Chem. 45. Martin C, Balasubramanian R, Dwyer AA, Au MG, Sidis Y, et al. (2011) The Role of the Prokineticin 2 Pathway in Human Reproduction: Evidence from the Study of Human and Murine Gene Mutations. Endocr Rev 32. 46. Doron-Faigenboim A, Stern A, Mayrose I, Bacharach E, Pupko T (2005) Selecton: a server for detecting evolutionary forces at a single amino-acid site. Bioinformatics 21: 2101–2103. 47. Stern A, Doron-Faigenboim A, Erez E, Martz E, Bacharach E, et al. (2007) Selecton 2007: advanced models for detecting positive and purifying selection using a Bayesian inference approach. Nucleic Acids Res 35: W506–511. 48. Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, et al. (2009) Predicting new molecular targets for known drugs. Nature 462: 175–181. 49. Okada T, Fujiyoshi Y, Silow M, Navarro J, Landau EM, et al. (2002) Functional role of internal water molecules in rhodopsin revealed by X-ray crystallography. Proc Natl Acad Sci U S A 99: 5982–5987. 50. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, et al. (2007) High-resolution crystal structure of an engineered human beta2- adrenergic G protein-coupled receptor. Science 318: 1258–1265. 51. Jaakola VP, Griffith MT, Hanson MA, Cherezov V, Chien EY, et al. (2008) The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 322: 1211–1217. 52. Bissantz C, Bernard P, Hibert M, Rognan D (2003) Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets? Proteins 50: 5–25. 53. Bywater RP (2005) Location and nature of the residues important for ligand recognition in G-protein coupled receptors. J Mol Recognit 18: 60–72. 54. Gloriam DE, Foord SM, Blaney FE, Garland SL (2009) Definition of the G protein-coupled receptor transmembrane bundle binding pocket and calculation of receptor similarities for drug design. J Med Chem 52: 4429–4442. 55. Shi L, Javitch JA (2002) The binding site of aminergic G protein-coupled receptors: the transmembrane segments and second extracellular loop. Annu Rev Pharmacol Toxicol 42: 437–467. 56. Wacker D, Fenalti G, Brown MA, Katritch V, Abagyan R, et al. (2010) Conserved binding mode of human beta2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography. J Am Chem Soc 132: 11443–11445. 57. McRobb FM, Capuano B, Crosby IT, Chalmers DK, Yuriev E (2010) Homology modeling and docking evaluation of aminergic G protein-coupled receptors. J Chem Inf Model 50: 626–637. 58. Brockhoff A, Behrens M, Niv MY, Meyerhof W (2010) Structural requirements of bitter taste receptor activation. Proc Natl Acad Sci U S A 107: 11110–11115. 59. Monnier C, Dode C, Fabre L, Teixeira L, Labesse G, et al. (2009) PROKR2 missense mutations associated with Kallmann syndrome impair receptor signalling activity. Hum Mol Genet 18: 75–81. 60. Vitale RM, Pedone C, De Benedetti PG, Fanelli F (2004) Structural features of the inactive and active states of the melanin-concentrating hormone receptors: insights from molecular simulations. Proteins 56: 430–448. 61. Vitale RM, Zaccaro L, Di Blasio B, Fattorusso R, Isernia C, et al. (2003) Conformational features of human melanin-concentrating hormone: an NMR and computational analysis. Chembiochem 4: 73–81. 62. Katritch V, Reynolds KA, Cherezov V, Hanson MA, Roth CB, et al. (2009) Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes. J Mol Recognit 22: 307–318. 63. Coetsee M, Millar RP, Flanagan CA, Lu ZL (2008) Identification of Tyr(290(6.58)) of the human gonadotropin-releasing hormone (GnRH) receptor as a contact residue for both GnRH I and GnRH II: importance for high-affinity binding and receptor activation. Biochemistry 47: 10305–10313. 64. Bhogal N, Donnelly D, Findlay JB (1994) The ligand binding site of the neurokinin 2 receptor. Site-directed mutagenesis and identification of neurokinin A binding residues in the human neurokinin 2 receptor. J Biol Chem 269: 27269–27274. PLoS ONE | www.plosone.org 16 November 2011 | Volume 6 | Issue 11 | e27990